Effect of plasma lipids, hypertension and APOE genotype on cognitive decline

Neurobiol Aging. 2012 Nov;33(11):2633-40. doi: 10.1016/j.neurobiolaging.2011.12.028. Epub 2012 Jan 27.

Abstract

We examined the combined effect of plasma lipids/hypertension and apolipoprotein E (APOE) genotype on cognitive function in elderly individuals. Plasma concentrations of high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), total cholesterol (TC), APOE, and history of hypertension were evaluated in 622 community-dwelling individuals aged 65 years and older. We investigated the associations between plasma lipids/hypertension and cognitive function in apolipoprotein E4 allele (APOE4) carrier (E4+) and APOE4 noncarrier (E4-) groups using 3-year longitudinal data. At baseline and 3 years later, cognitive scores were correlated with plasma APOE levels in both E4- and E4+, and HDL level in E4-. The combination of hypertension and E4+, but not E4-, was associated with a significant deterioration in cognitive function during the 3-year follow-up. Our findings suggest that an interaction between APOE and HDL is facilitated by APOE4, and is possibly linked with a protective effect on cognitive decline in later life. The findings also indicate a synergistic effect of an APOE4 allele and hypertension on the acceleration of cognitive decline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Apolipoproteins E / blood
  • Apolipoproteins E / genetics*
  • Cognition / physiology*
  • Cognition Disorders / blood
  • Cognition Disorders / etiology*
  • Cognition Disorders / genetics
  • Female
  • Genotype
  • Humans
  • Hypertension / complications
  • Hypertension / genetics*
  • Hypertension / physiopathology*
  • Lipids / blood*
  • Male
  • Middle Aged

Substances

  • Apolipoproteins E
  • Lipids